SHLD2 and cancer: In conclusion, our study proposes a mechanistic model that USP25 deubiquitinates and modifies SHLD2 with K63‐linked polyubiquitin chains at the K64 site, thereby promoting NHEJ repair, which in turn decreases chemosensitivity in cancer cells.